Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
 

Caledonia Investments plc

Director/PDMR Shareholding Notification

 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

 

18,837

0.03

18,837

 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

 

15,776

0.03

15,776

 

 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

 

APPENDIX 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of £14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

 

 

c)

 

 

 

Price(s) and volume(s)

 

 

1. Exercise of PSS awards

 

2. Exercise of options

 

3. Call of DBP awards

 

4. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

19,749

 

£14.46

12,707

£0.00

11,302

£29.10

43,758

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards, exercise of options with an exercise price of £14.46 and call of DBP awards: 43,758

 

Sale of shares: 43,758

 

Exercise of PSS awards (£nil), exercise of options with an exercise price of £14.46 (£14.46) and call of DBP awards (£nil): weighted average price £4.20

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards, options with an exercise price of £14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen Anthony King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

 

Price(s) and volume(s)

 

 

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

11,194

 

£0.00

13,365

£29.10

24,559

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards and call of DBP awards: 24,559

 

Sale of shares: 24,559

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

15,776

 

£0.00

18,837

£29.10

34,613

 

 

 

 

 

d)

 

 

 

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

Exercise of PSS awards and call of DBP awards: 34,613

 

Sale of shares: 34,613

 

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSUFDAFWSEEM
Date   Source Headline
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares
7th Jan 202211:40 amRNSUnaudited net asset value and portfolio update
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20214:44 pmRNSDisposal
20th Dec 202110:00 amRNSDirector Declaration
17th Dec 20215:32 pmRNSTransaction in Own Shares
10th Dec 20215:16 pmRNSTransaction in Own Shares
7th Dec 20219:59 amRNSNet Asset Value(s)
30th Nov 20215:30 pmRNSTotal Voting Rights
26th Nov 20214:49 pmRNSTransaction in Own Shares
23rd Nov 20217:00 amRNSBoard Changes
23rd Nov 20217:00 amRNSHalf-year Report
17th Nov 20217:00 amRNSDisposal
4th Nov 202111:22 amRNSNet Asset Value(s)
1st Nov 20219:35 amRNSTotal Voting Rights
29th Oct 20214:49 pmRNSTransaction in Own Shares
15th Oct 20214:57 pmRNSTransaction in Own Shares
8th Oct 20215:16 pmRNSTransaction in Own Shares
7th Oct 202110:48 amRNSNet Asset Value(s)
30th Sep 20215:02 pmRNSTotal Voting Rights
30th Sep 20214:59 pmRNSTransaction in Own Shares
30th Sep 20211:52 pmRNSTransaction in Own Shares
24th Sep 20214:57 pmRNSTransaction in Own Shares
17th Sep 20215:05 pmRNSTransaction in Own Shares
10th Sep 20215:05 pmRNSTransaction in Own Shares
3rd Sep 20215:04 pmRNSTransaction in Own Shares
3rd Sep 202112:12 pmRNSDirector/PDMR Shareholding
31st Aug 20216:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.